Inventor · disambiguated record
Jagdeep Nanchahal
Also filed as: NANCHAHAL JAGDEEP
9 granted patents·9 pending applications·14 citations·filing 2010–2023
83Inventor score
Files with180 THERAPEUTICS LP7UNIV OXFORD INNOVATION LTD5NANCHAHAL JAGDEEP3THE KENNEDY TRUST FOR RHEUMATOLOGY RES2LARSEN GLENN1
Top patents by PatentIndex Score
18 records- 0187US10669334B2Treatment for Dupuytren's diseaseUNIV OXFORD INNOVATION LTD·Filed 2019·Granted Jun 2, 2020·2 cites·11 claims
- 0282US10273296B2Treatment for dupuytren's diseaseUNIV OXFORD INNOVATION LTD·Filed 2015·Granted Apr 30, 2019·3 cites·11 claims
- 0381US11220540B2Methods for reducing post-operative cognitive dysfunction (POCD)THE KENNEDY TRUST FOR RHEUMATOLOGY RES·Filed 2019·Granted Jan 11, 2022·2 cites·15 claims
- 0479US9138458B2Treatment for dupuytren's diseaseNANCHAHAL JAGDEEP·Filed 2011·Granted Sep 22, 2015·6 cites·9 claims
- 0574US11613570B2Method of treating dupuytren's disease using a pre-filled syringe180 THERAPEUTICS LP·Filed 2022·Granted Mar 28, 2023·0 cites·2 claims
- 0674US2023220060A1Method of treating early stage dupuytren's disease180 THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 0772US12325744B2Methods for reducing post-operative cognitive dysfunction (POCD)THE KENNEDY TRUST FOR RHEUMATOLOGY RES·Filed 2021·Granted Jun 10, 2025·0 cites·12 claims
- 0872US11400154B2Method of treating a localized fibrotic disorder using an IL-33 antagonist180 THERAPEUTICS LP·Filed 2019·Granted Aug 2, 2022·0 cites·18 claims
- 0968US10500273B2Method of treating a localized fibrotic disorder using an IL-33 antagonistLARSEN GLENN·Filed 2016·Granted Dec 10, 2019·1 cites·13 claims
- 1066US2021386855A1Method of treating a localized fibrotic disorder using a tnf receptor 2 antagonist180 THERAPEUTICS LP·Filed 2021·Application pending·0 cites
- 1163US12344667B2Method of treating early stage Dupuytren's disease180 THERAPEUTICS LP·Filed 2017·Granted Jul 1, 2025·0 cites·2 claims
- 1256US2023046828A1Polypeptides Related to HMGB1 Useful for Promoting Tissue Regeneration, Compositions Comprising Same, and Uses ThereofUNIV OXFORD INNOVATION LTD·Filed 2022·Application pending·0 cites
- 1343US2022023387A1Prophylactic and therapeutic uses of fully reduced forms of hmgb1 in conditions involving organsUNIV OXFORD INNOVATION LTD·Filed 2019·Application pending·0 cites
- 1443US2019225682A1Method of treating localized fibrotic disorders using an il-33/tnf bispecific antibody180 THERAPEUTICS LP·Filed 2017·Application pending·0 cites
- 1543US2021260157A1Prophylactic uses of partially or fully reduced forms of hmgb1 prior to injuryUNIV OXFORD INNOVATION LTD·Filed 2019·Application pending·0 cites
- 1640US2019202907A1Method of treating systemic fibrotic disorders using an il-33/tnf bispecific antibody180 THERAPEUTICS LP·Filed 2017·Application pending·0 cites
- 1730US2014056960A1Methods for Improving Fracture Healing and Bone FormationNANCHAHAL JAGDEEP·Filed 2011·Application pending·0 cites
- 1827US2012213826A1Use of Pro-Inflammatory Compounds for Promoting Bone FormationNANCHAHAL JAGDEEP·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →